Search Results 831-840 of 19286 for Myocardium

1. Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation - Mayo Clinic

   ... myocardial infarction within 6 months prior to study entry; unevaluated new onset angina within 3 months or unstable angina (angina symptoms at rest) or ...

2. Cardiovascular Medicine - Clinical trials

   The purpose of this study is to prospectively determine if direct current cardioversion (DCCV) results in myocardial injury as assessed by changes in high ...

3. Futibatinib and Pembrolizumab for the Treatment of Advanced or Metastatic FGF19 Positive BCLC Stage A, B, or C Liver Cancer - Mayo Clinic

   Clinically significant or uncontrolled cardiac disease, including unstable angina, acute myocardial infarction within 6 months from day 1 of study treatment ...

4. Focal MR-Guided Focused Ultrasound Treatment Of Localized Intermediate Risk Prostate Lesions - Mayo Clinic

   Patients with documented myocardial infarction within 40 days prior to enrollment; Congestive heart failure NYHA class IV; Patients with unstable arrhythmia ...

5. A Study Of Inosine Treatment To Slow Clinical Decline In Patients With Parkinson's Disease

   History of myocardial infarction or stroke; Symptomatic congestive heart failure with a documented ejection fraction below 45%; History of severe chronic ...

6. Quinine (oral route) - Side effects & dosage - Mayo Clinic

   Bradycardia (slow heartbeat) or; Heart disease (eg, myocardial ischemia) or; Hypokalemia (low potassium in the blood), uncorrected or; Sick sinus syndrome (type ...

7. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies - Mayo Clinic

   Significant cardiovascular disease such as uncontrolled or symptomatic arrhythmias, congestive heart failure, or myocardial infarction within 6 months of ...

8. A Study to Determine the Effectiveness and Safety of Luspatercept in Patients with Myelodysplastic/ Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis - Mayo Clinic

   History of myocardial infarction, stroke, embolism, deep vein or arterial thrombosis ≤ 6 months prior to registration, or congestive heart failure ...

9. Pembrolizumab and Lenvatinib in Clear Cell Ovarian Cancer - Mayo Clinic

   ... myocardial infarction within the past 6 months, or serious cardiac arrhythmia within the past 6 months. * Resting corrected QT interval (QTc) interval using ...

10. Tucatinib and Trastuzumab for Patients with HER2-positive Metastatic Colorectal Cancer - Mayo Clinic

    Have known myocardial infarction, unstable angina, cardiac or other vascular stenting, angioplasty, or cardiac surgery within 6 months prior to first dose ...